EWTX Stock Analysis: Buy, Sell, or Hold?
EWTX - Edgewise Therapeutics, Inc. Common Stock
$41.27
-4.14 (-9.12%)
▼
5d:
+2.92%
30d:
+25.36%
90d:
+25.75%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026
22d
Get Alerted When EWTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EWTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: EWTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: EWTX is currently trading at $41.27, which is considered extended relative to its 30-day fair value range of $34.67 to $42.64.
Technical Outlook: Technically, EWTX is in a strong uptrend. Immediate support is located at $38.36, while resistance sits at $48.40. Short-term momentum is weak, with the stock down 9.1% recently.
Market Sentiment: EWTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $49.15 (+19.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EWTX is in a strong uptrend. Immediate support is located at $38.36, while resistance sits at $48.40. Short-term momentum is weak, with the stock down 9.1% recently.
Market Sentiment: EWTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $49.15 (+19.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$34.67 -
$42.64
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
55.3%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.1%)
- BULLISH: Trading below Wall St target ($49.15)
Trading Range Analysis
30-Day Trading Range
$34.67 -
$42.64
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$38.36
Resistance Level
$48.40
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-27.12
Wall Street Target
$49.15
(+19.1%)
Share & Embed Analysis
Last updated: July 14, 2026 6:14 AM ET
Data refreshes hourly during market hours. Next update: 7:14 AM
Data refreshes hourly during market hours. Next update: 7:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EWTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Joanne M Donovan
SELL
28662 shares
2026-04-01
Badreddin Edris
SELL
115471 shares
2026-01-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 66 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1051 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 64 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 50 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$124 | 61 BUY |
